arrow
T

Thor Petersen

Aarhus University
H指数:48
被引数:7,908

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting disease progression in multiple sclerosis with clinically accessible information and technology

利用临床可获取的信息和技术预测多发性硬化症的疾病进展

2026-04-190
OAAI
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis

κ游离轻链指数在原发性进展型多发性硬化患者中的预后价值

2025-11-070
OAAI
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study
2023-12-194
OAAI
Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial
2023-12-065
OAAI
Cannabis-Based Medicine for Neuropathic Pain and Spasticity-A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
2023-07-2811
OAAI
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

继发性进行性多发性硬化症的风险由地理位置决定,但可以改变

BRAIN
IF11.7
2023-06-275
OAAI
Comparative effectiveness in multiple sclerosis: A methodological comparison

多发性硬化症的比较效果: 方法学比较

2023-02-193
PRE
Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis An International Registry Study
2022-06-1418
OA
Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)

研究多发性硬化症病程早期运动疗法的潜在疾病改善和神经保护功效: 早期多发性硬化症运动研究 (EMSES)

2022-03-1624
PRE
The effect of spinal manipulative therapy on pain relief and function in patients with chronic low back pain: an individual participant data meta-analysis
2021-09-0120
OAAI
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a
2021-01-125
OAAI
Initial high-efficacy disease-modifying therapy in multiple sclerosis A nationwide cohort study
2020-08-25101
PREAI
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis
2020-06-1514
PREAI